Wells Fargo sees the appointment of Ashley McEvoy as CEO of Insulet (PODD) as a significant positive for the company given McEvoy’s experience and track record. Wells look forward to hearing about her vision for the company on the May 8 earnings call. The firm has an Overweight rating on the shares with a price target of $322.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD:
- Insulet names Ashley McEvoy as President and CEO, succeeding Jim Hollingshead
- Insulet expects to exceed previously issued Q1 revenue guidance
- Insulet price target lowered to $325 from $340 at RBC Capital
- Insulet Closes $450 Million Senior Notes Issuance
- Insulet’s Strong Performance and Growth Prospects Drive Buy Rating